Eli Lilly beats quarterly revenue estimates on Mounjaro strength
© Reuters. Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo
Mounjaro, currently approved for diabetes, has been in high demand since its U.S. launch last year. The drug, known chemically as tirzepatide, is expected to be approved for use in weight loss by the end of this year.) are ahead in the race to grab a slice of an estimated $100 billion market for new generation obesity treatments known as GLP-1 agonists.
Singapore Latest News, Singapore Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Eli Lilly beats quarterly revenue estimates on Mounjaro strengthEli Lilly (LLY.N) beat Wall Street's revenue estimates for the third quarter on Thursday, lifted by strong demand for its diabetes drug Mounjaro that brought in over a billion dollars in sales.
Read more »
Eli Lilly’s stock drops after surprise profit is reported but full-year outlook was slashedTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Read more »
Eli Lilly Stock Slumps as Earnings Guidance Slashed DramaticallyLilly slashes its guidance for full-year earnings to a range of $6.50 to $6.70 a share, having raised its outlook in August to a range of $9.70 to $9.90.
Read more »
Eli Lilly falls after cutting full-year profit forecastEli Lilly falls after cutting full-year profit forecast
Read more »
Eli Roth's Thanksgiving Rated R for 'Strong Bloody Horror Violence and Gore'Thanksgiving is rated R for 'strong bloody horror violence and gore, pervasive language and some sexual material.'
Read more »
Eli Ward, Jason Arcilla ‘Serenade’ Gwen Stefani on NBC's 'The Voice'The Team Gwen pair tackled Bread’s “Make It With You,” which led the Billboard Hot 100 for a single week in 1970.
Read more »